deltatrials
Completed PHASE4 NCT01614847

Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears

Sponsor: Thomas O Salmon, OD, PhD

Conditions Dry Eye
Interventions Artificial tears
Updated 8 times since 2017 Last updated: Apr 2, 2020 Started: Jun 30, 2012 Primary completion: Aug 31, 2012 Completion: Aug 31, 2012

A PHASE4 clinical study on Dry Eye, this trial is completed. The trial is conducted by Thomas O Salmon, OD, PhD and has accumulated 8 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 3 earlier versions

  1. May 2020 — Jan 2021 [monthly]

    Completed PHASE4

    Phase: NA → PHASE4

  2. Jun 2018 — May 2020 [monthly]

    Completed NA

  3. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Thomas O Salmon, OD, PhD
Data source: Northeastern State University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Tahlequah, United States